The Effects of Sports Drinks on Urinary Lithogenicity

Urolithiasis Clinical Trial

Official title:

The Effects of Sports Drinks on Urinary Lithogenicity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00381277
• Other study ID #: DG-1
• Status: Completed
• Phase: N/A
• First received: September 26, 2006
• Last updated: February 18, 2011
• Start date: March 2006
• Est. completion date: September 2006

Study information

• Verified date: February 2011
• Source: VA New York Harbor Healthcare System
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardUnited States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The effect of sports drinks on the tendency to form kidney stones has not been assessed. Patients will drink 1 liter a day of 2 sports drinks and collect urine to determine changes in urine chemistry that may decrease the risk of forming stones.

Description:

Participants will drink 1 liter of water each day for one week in the control period, then 1 liter of sports drink each day for one week during the experimental period. Urine collections will be performed during both periods. Diet will be chosen by participants and a food diary will be kept so that participants can replicate diet during the urine collections.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: September 2006
• Est. primary completion date: March 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• age 18-80 years old

• men and women

• able to sign informed consent

Exclusion Criteria:

• history of kidney stones

• bone disease

• parathyroid disease

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Urolithiasis

Intervention

Drug:
• Gatorade

• Performance

Locations

Country	Name	City	State
United States	New York Harbor VAMC	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
VA New York Harbor Healthcare System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Urinary supersaturation of calcium oxalate
Primary	Urinary citrate excretion
Primary	Urinary calcium excretion
Primary	Urinary sodium excretion